Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.30 EUR | +1.01% | +1.29% | +2.22% |
09/12 | Nuvalent, Inc. Appoints Grant Bogle to Board of Directors | CI |
03/12 | Ipsen: exclusive worldwide licensing agreement with Biomunex | CF |
Capitalization | 906.66Cr 952.57Cr 840.22Cr 747.32Cr 1.35TCr 81TCr 1.5TCr 10TCr 3.86TCr 33TCr 3.58TCr 3.5TCr 1,44900Cr | P/E ratio 2024 * |
14.7x | P/E ratio 2025 * | 12.7x |
---|---|---|---|---|---|
Enterprise value | 859.52Cr 903.04Cr 796.53Cr 708.47Cr 1.28TCr 77TCr 1.42TCr 9.92TCr 3.66TCr 31TCr 3.39TCr 3.32TCr 1,37300Cr | EV / Sales 2024 * |
2.46x | EV / Sales 2025 * | 2.14x |
Free-Float |
41.56% | Yield 2024 * |
1.09% | Yield 2025 * | 1.12% |
Last Transcript: Ipsen
1 day | +1.01% | ||
1 week | +1.29% | ||
Current month | +0.82% | ||
3 months | +0.27% | ||
6 months | -10.25% | ||
Current year | +2.22% |
Director | Title | Age | Since |
---|---|---|---|
David Loew
CEO | Chief Executive Officer | 57 | 01/07/2020 |
Chief Executive Officer | 55 | 01/01/2020 | |
Chief Tech/Sci/R&D Officer | 57 | 22/09/2023 |
Manager | Title | Age | Since |
---|---|---|---|
Henri Beaufour
BRD | Director/Board Member | 59 | 19/09/2005 |
Antoine Flochel
BRD | Director/Board Member | 59 | 30/08/2005 |
Chairman | 66 | 22/11/2010 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.83% | 2 M€ | +15.94% | ||
0.43% | 177 M€ | +10.64% | ||
0.31% | 3 M€ | +11.67% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.01% | +1.29% | +6.98% | +19.89% | 949.66Cr | ||
-0.50% | -0.03% | +33.70% | +229.18% | 72TCr | ||
+0.03% | +0.86% | +17.04% | +108.44% | 49TCr | ||
-0.25% | -3.60% | -3.36% | -10.05% | 36TCr | ||
-0.51% | -3.36% | +17.68% | +41.50% | 31TCr | ||
-2.69% | +0.39% | -2.65% | +38.62% | 26TCr | ||
-1.32% | -0.94% | +0.20% | -32.16% | 24TCr | ||
-1.78% | -0.40% | +3.85% | +25.71% | 21TCr | ||
-0.69% | -4.70% | +4.77% | +18.92% | 20TCr | ||
-0.68% | -0.85% | +2.46% | +29.72% | 15TCr | ||
Average | -0.50% | -0.74% | +8.07% | +46.98% | 29.6TCr | |
Weighted average by Cap. | -0.48% | -0.51% | +13.05% | +82.75% |
2024 * | 2025 * | |
---|---|---|
Net sales | 349.48Cr 367.18Cr 323.87Cr 288.06Cr 520Cr 31TCr 576.28Cr 4.03TCr 1.49TCr 13TCr 1.38TCr 1.35TCr 56TCr | 369.83Cr 388.56Cr 342.73Cr 304.84Cr 550.28Cr 33TCr 609.84Cr 4.27TCr 1.58TCr 14TCr 1.46TCr 1.43TCr 59TCr |
Net income | 63Cr 66Cr 58Cr 52Cr 94Cr 5.62TCr 103.88Cr 726.93Cr 268.35Cr 2.31TCr 248.48Cr 243.12Cr 10TCr | 73Cr 77Cr 68Cr 61Cr 109.26Cr 6.55TCr 121.09Cr 847.37Cr 312.81Cr 2.69TCr 289.65Cr 283.4Cr 12TCr |
Net Debt | -47Cr -50Cr -44Cr -39Cr -70Cr -4.2TCr -78Cr -544Cr -200.82Cr -1.73TCr -185.95Cr -181.94Cr -7.53TCr | -116.05Cr -121.93Cr -107.55Cr -96Cr -172.68Cr -10TCr -191.37Cr -1.34TCr -494.36Cr -4.25TCr -457.75Cr -447.88Cr -19TCr |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 110.30 € | +1.01% | 46,278 |
09/24/09 | 109.20 € | +0.46% | 75,564 |
06/24/06 | 108.70 € | -1.72% | 90,175 |
05/24/05 | 110.60 € | +0.27% | 75,670 |
04/24/04 | 110.30 € | -0.72% | 88,156 |
Real-time Euronext Paris, December 10, 2024 at 10:06 pm IST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- IPN Stock
MarketScreener is also available in this country: United States.
Switch edition